Altered Substrate Specificity of Drug-Resistant Human Immunodeficiency Virus Type 1 Protease

Resistance to human immunodeficiency virus type 1 protease (HIV PR) inhibitors results primarily from the selection of multiple mutations in the protease region. Because many of these mutations are selected for the ability to decrease inhibitor binding in the active site, they also affect substrate...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Virol
Autors principals:	Dauber, Deborah S., Ziermann, Rainer, Parkin, Neil, Maly, Dustin J., Mahrus, Sami, Harris, Jennifer L., Ellman, Jon A., Petropoulos, Christos, Craik, Charles S.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2002
Matèries:	Vaccines and Antiviral Agents
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC135855/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11773410/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.76.3.1359-1368.2002
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!